SV Life Sciences to manage $100 mln dementia research fund

LONDON, Oct 21 (Reuters) - The world's first fund focused on preventing and treating dementia was launched on Wednesday, backed by leading drug companies, with venture capital firm SV Life Sciences appointed as fund manager.